Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Zimran

Showing results (31-40 of 238) with videos related to

Pageof 24
Sort By:
Blood Cells, Molecules & Diseases|February 11, 2017
Children with type 1 Gaucher disease: Changing profiles in the 21st centuryDeborah Elstein, Gheona Altarescu, Aya Abrahamov, et al.
Blood Cells, Molecules & Diseases|October 23, 2012
Evolving features in type 3 Gaucher disease on long-term enzyme replacement therapyDeborah Elstein, Ayala Abrahamov, Gheona Altarescu, et al.
Blood Cells, Molecules & Diseases|October 6, 2010
Vitamin D Receptor (VDR) polymorphic variants in patients with cancer and Gaucher diseaseMichelle Lieblich, Gheona Altarescu, Ari Zimran, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|April 21, 2009
Cementless total hip arthroplasties in Gaucher disease: long-term follow-upEhud Lebel, Deborah Elstein, Ari Zimran, et al.
Pediatric Cardiology|September 29, 2009
Vitamin D receptor (VDR) polymorphisms in the cardiac variant of Gaucher diseaseAllen Greenwood, Gheona Altarescu, Ari Zimran, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2011
Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher diseaseAvigayil Ribner, Gheona Altarescu, Ari Zimran, et al.
American Journal of Hematology|July 25, 2003
D-dimer assay in Gaucher disease: correlation with severity of bone and lung involvementDavid Shitrit, Bernard Rudensky, Ari Zimran, et al.
Blood Cells, Molecules & Diseases|March 30, 2007
A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher diseaseAri Zimran, Kenneth Loveday, Candida Fratazzi, et al.
Clinical Rheumatology|April 27, 2010
Effect of vitamin D receptor (VDR) genotypes on the risk for osteoporosis in type 1 Gaucher diseaseAllen Greenwood, Deborah Elstein, Ari Zimran, et al.
Clinical Therapeutics|October 9, 2007
Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studiesGregory M Pastores, Deborah Elstein, Martin Hrebícek, et al.
Pageof 24

Showing results (31-40 of 238) with videos related to

Sort By:
Pageof 24
Blood Cells, Molecules & Diseases|February 11, 2017
Children with type 1 Gaucher disease: Changing profiles in the 21st centuryDeborah Elstein, Gheona Altarescu, Aya Abrahamov, et al.
Blood Cells, Molecules & Diseases|October 23, 2012
Evolving features in type 3 Gaucher disease on long-term enzyme replacement therapyDeborah Elstein, Ayala Abrahamov, Gheona Altarescu, et al.
Blood Cells, Molecules & Diseases|October 6, 2010
Vitamin D Receptor (VDR) polymorphic variants in patients with cancer and Gaucher diseaseMichelle Lieblich, Gheona Altarescu, Ari Zimran, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|April 21, 2009
Cementless total hip arthroplasties in Gaucher disease: long-term follow-upEhud Lebel, Deborah Elstein, Ari Zimran, et al.
Pediatric Cardiology|September 29, 2009
Vitamin D receptor (VDR) polymorphisms in the cardiac variant of Gaucher diseaseAllen Greenwood, Gheona Altarescu, Ari Zimran, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2011
Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher diseaseAvigayil Ribner, Gheona Altarescu, Ari Zimran, et al.
American Journal of Hematology|July 25, 2003
D-dimer assay in Gaucher disease: correlation with severity of bone and lung involvementDavid Shitrit, Bernard Rudensky, Ari Zimran, et al.
Blood Cells, Molecules & Diseases|March 30, 2007
A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher diseaseAri Zimran, Kenneth Loveday, Candida Fratazzi, et al.
Clinical Rheumatology|April 27, 2010
Effect of vitamin D receptor (VDR) genotypes on the risk for osteoporosis in type 1 Gaucher diseaseAllen Greenwood, Deborah Elstein, Ari Zimran, et al.
Clinical Therapeutics|October 9, 2007
Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studiesGregory M Pastores, Deborah Elstein, Martin Hrebícek, et al.
Pageof 24